Abstract
The action of immunotoxins (ITs) on target cells can be divided into three steps: 1) binding to the cell-surface target antigen, 2) translocation from the cell surface membrane to the cytosol compartment, and 3) inactivation of intracellular substrate by the toxin moiety [1]. IT binding to target cell is typically very fast. In most cases the binding of radiolabeled monoclonal antibody to target cells reaches saturation within 30 minutes [2]. It has also been shown that removal of unbound IT 10 minutes after treatment yielded the same degree of target cell intoxication in vitro as that obtained without removing the unbound IT [3]. The inactivation of ribosomes by toxin in a cell-free system was completed in 30 minutes [4]. With few exceptions [5, 6, 17], however, the kinetics of protein synthesis inhibition in intact cells by an IT is generally much slower; often from several hours to 60 hours of incubation is necessary to reach 50% protein synthesis inhibition (see Table 1). This suggests that the translocation of IT from the cell surface to the cytosol is the limiting step for intoxication.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Esworthy, R.S., and Neville, D.M., Jr. (1984) A comparative study of ricin and diphtheria toxin-antibody-conjugate kinetics on protein synthesis inactivation. J. Biol. Chem., 259, 11496–11504.
Mason, D.W., and Williams, A.F. (1980) The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem. J., 187, 1–20.
Ramakrishnan, S., and Houston, L.L. (1984) Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies. Cancer Res., 44, 201–208.
Olsnes, S., Sandvig, K., Refsnes, K., and Pihl, A. (1976) Rates of different steps involved in the inhibition of protein synthesis by the toxin lectins abrin and ricin. J. Biol. Chem., 257, 3985–3992.
Canevari, S., Orlandi, R., Ripamonti, M., Tagliabue, E., Aguanno, S., Miotti, S., Menard, S., and Colnaghi, M.I. (1985) Ricin A chain conjugate with monoclonal antibodies selectively kill human carcinoma cell in vitro. J. Natl Cancer Inst. 75, 831–839.
Wiels, J., Junqua, S., Dujardin, P., Le Pecq, J.-B, and Tursz, T. (1984) Properties of immunotoxins against a glycolipid antigen associated with Burkitt’s lymphoma. Cancer Res., 44, 129–133.
Samelson, L.E., Harford, J.B., and Klausner, R.D. (1985) Identification of the components of the murine T cell antigen receptor complex. Cell, 43, 223–231.
Laurent, G., Kuhlein, E., Casellas, P., Canat, X., Carayon, P., Poncelet, P., Correll, S., Rigal, F., and Jansen, F.K. (1986) Determination of sensitivity of fresh leukemia cells to immunotoxins. Cancer Res., 46, 2289–2294.
Pirker, R., FitzGerald, D.J., Hamilton, T.C., Ozols, R.F., Willingham, M.C., and Pastan, I. (1985) Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines. Cancer Res., 45, 751–757.
Godal, A., Fodstad, O., Morgan, A.C., and Pihl, A. (1986) Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins. J. Natl Cancer Inst. 77, 1247–1253.
Krolick, K.A., Uhr, J.W., Slavin, S., and Vitetta, E.S. (1982) In vitro therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. J. Exp. Med., 155, 1797–1809.
Low, M.G., and Kincade, P.W. (1985) Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoprotein. Nature, 318, 62–64.
Casellas, P., Carriere, D., Gros, O., Laurent, J.C., Poncelet, P., and Jansen, F.K. (1984) Properties of antibody-ricin A chain conjugates (immunotoxins) in specific cell killing. FEMS Symposium No. 24. Bacterial Protein Toxin. Academic Press, London, pp 227–234.
Magnani, J.L., Brockhaus, M., Smith, D.F., Ginsburg, U., Blaszczyk, M., Mitchell, K., Steplewski, Z., and Koprowski, H. (1981) A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science, 212, 55–56.
Nudelman, E., Kannagi, R., Hakomori, S., Lipinski, M., Wiels, J., Parson, M., Fellous, M., and Tursz, T. (1983) A Burkitt’s lymphoma associated glycolipid antigen defined by monoclonal antibody. Science, 220, 508–511.
Pikel, C.S., Lloyd, K.O., Travassos, L.A., Dippold, W.G., Oettgen, H.F., and Lloyd, J.O. (1982) GD3, a prominent ganglioside of human melanoma. Detection and characterization by mouse monoclonal antibody. J. Exp. Med., 155, 1133–1147.
Youle, R.J., Uckun, F.M., Vallera, D.A., and Colombatti, M. (1986) Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen. J. Immunol., 136, 93–98.
Vallera, D.A., Quinones, R.R., Azemove, S.M., and Soderling, C.C. (1984) Monoclonal antibody-toxin conjugate reactive against human T lymphocytes. Transplantation, 37, 387–392.
Colombatti, M., and Bron, C. (1985) Sensitivity of target cells to immunotoxins: Possible role of cell-surface antigens. Immunology, 55, 331–338.
Seth, P., FitzGerald, D.J., Willingham, M.C., and Pastan, I. (1984) Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxinepdiermal growth factor conjugate. J. Virol., 51, 650–655.
Kronke, M., Schlick, E., Waldmann, T., Vitetta, E.S., and Greene, W.C. (1986) Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal antiinterleukin 2 receptor antibody-ricin A chain conjugates: Potentiation by ammonium chloride and monensin. Cancer Res., 46, 3295–3298.
Ramakrishnan, S., and Houston, L.L. (1984) Inhibition of human acute lymphoblastic leukemia cells by immunotoxins: Potentation by chloroquine. Science, 223, 58–61.
Raso, V., and Lawrence, J. (1984) Carboxylic ionophores enhance the cytotoxic potency of ligand- and antibody-derivered ricin A chain. J. Exp. Med., 160, 1234–1240.
Dautry-Varsat, A., Ciechanover, A., and Lodish, H.F. (1983) pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Nat. Acad. Sci. USA, 80, 2258–2262.
Vallera, D.A., Ash, R.C., Zanjani, E.D., Kersey, J.H., Le Bien, T.L., Beverley, P.C., Neville, D.M., Jr., and Youle, R.J. (1983) Anti-T-cell reagents for human bone marrow transplantation: Ricin linked to three monoclonal antibodies. Science, 222, 512–515.
Casellas, P., Bourrie, B.J., Gros, P., and Jansen, F.K. (1984) Kinetics of cytotoxicity induced by immunotoxins. J. Biol. Chem., 259, 9359–9364.
Marsh, J.W., and Neville, D.M., Jr. (1986) Kinetic comparison of ricin immunotoxins: Biricin conjugate has potentiated cytotoxicity. Biochemistry, 25, 4461–4467.
Bjorn, M., Groestema, G., and Scalapino, L. (1986) Antibody Pseudomonas exotoxin A conjugates cytotoxic to human breast cancer cells in vitro. Cancer Res., 46, 3262–3267.
Pirker, R., FitzGerald, D.J., Hamilton, T.C., Ozols, R.F., Laird, W., Frankel, A., Willingham, M.C., and Pastan, I. (1985) Characterization of immunotoxins active against ovarian cancer cells. J. Clin. Invest., 76, 1261–1267.
Tietze, C., Schelsinger, P., and Stahl, P. (1980) Chloroquine and ammonium ion inhibit receptor mediated endocytosis of mannose-glycoconjugates by macrophages: Apparent inhibition of receptor reclycling. Biochem. Biophys. Res. Comm., 93, 1–8.
Ohkuma, S., and Poole, B. (1978) Fluorescence probe measurement of the intralysomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA, 75, 3327–3331.
Hart, P.D., Young, M.R., Jordand, M.M., Perkins, W.J., and Geisow, M.J. (1983) Chemical inhibitors of phagosome lysosome fusion in culutred macrophages also inhibit saltatory lysosomal movements. J. Exp. Med., 158, 477–492.
Vitetta, E.S., Fulton, R.J., and Uhr, J.W. (1984) Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain. J. Exp. Med., 160, 341–346.
Jansen, F.K., Blythman, H.E., Carriere, D., Casellas, P., Gros, O., Gros, P., Laurent, J.C., Paolucci, F., Pau, B., Poncelet, P., Richer, G., Vidal, H., and Voisin, G.A. (1982) Immunotoxins: Hybrid molecules combining high specificity and potent cytotoxicity. Immunol. Rev., 62, 185–216.
FitzGerald, D.J., Waldmann, T.A., Willingham, M.C., and Pastan, I. (1984) Pseudomonas exotoxin-anti-TAC: Cell specific immunotoxin active against cells expressing the human T cell growth factor receptor. J. Clin. Invest., 74, 966–971.
Ray, B., and Wu, H.C. (1981) Enhancement of cytotoxicities of ricin and Pseudomonas toxin in Chinese hamster ovary cells by Nigericin. Mol. Cell. Biol., 1, 552–559.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Kim, Y.W. (1988). Kinetic analysis of cytotoxicity. In: Frankel, A.E. (eds) Immunotoxins. Cancer Treatment and Research, vol 37. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1083-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1083-9_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8419-2
Online ISBN: 978-1-4613-1083-9
eBook Packages: Springer Book Archive